Clinical Trial

The Efficacy and Safety of Transcutaneous Auricular Vagus Nerve Stimulation for Depression in PD

Study acronym: PD-D-taVNS
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 1, 2026 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is a double blind comparative study examining the effectiveness of the transcutaneous auricular vagus nerve stimulation treatment on Parkinson's disease patients with depression. The investigators hypothesize that taVNS will improve depression and cortical activity in Parkinson's disease patients with depression.
Trial Details
NCT Number NCT07679529
Lead Sponsor The First Affiliated Hospital with Nanjing Medical University
Collaborators: The Second People's Hospital of Huai'an
Conditions Parkinson Disease
Enrollment 30 participants
Start Date 2026-07-01
Primary Completion 2026-08-01 (estimated)
Study Completion 2026-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-01